Header cover image

Chinese (SSE) Drug Retail Industry Analysis

UpdatedJun 10, 2026
DataAggregated Company Financials
Companies9
  • 7D-3.7%
  • 3M-16.1%
  • 1Y-19.2%
  • YTDn/a

Over the last 7 days, the Drug Retail industry has dropped 5.6%, driven by DaShenLin Pharmaceutical Group declining 5.0%. Overall the industry is down 20% in 12 months. Looking forward, earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the Chinese Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 10 Jun 2026CN¥77.1bCN¥122.8bCN¥4.2b22.4x18.3x0.6x
Fri, 08 May 2026CN¥89.8bCN¥123.2bCN¥4.2b26.6x21.4x0.7x
Sun, 05 Apr 2026CN¥88.4bCN¥121.2bCN¥3.6b24.6x24.6x0.7x
Tue, 03 Mar 2026CN¥94.3bCN¥121.2bCN¥3.6b27.2x26.2x0.8x
Thu, 29 Jan 2026CN¥96.9bCN¥121.2bCN¥3.6b28.7x26.9x0.8x
Sat, 27 Dec 2025CN¥91.9bCN¥121.2bCN¥3.6b27.8x25.5x0.8x
Mon, 24 Nov 2025CN¥86.9bCN¥121.2bCN¥3.6b28.5x24.1x0.7x
Wed, 22 Oct 2025CN¥91.0bCN¥120.6bCN¥3.3b30.6x27.3x0.8x
Fri, 19 Sep 2025CN¥91.7bCN¥120.6bCN¥3.4b29.8x27.2x0.8x
Sun, 17 Aug 2025CN¥90.3bCN¥120.5bCN¥3.2b30.4x27.9x0.8x
Tue, 15 Jul 2025CN¥93.1bCN¥120.4bCN¥3.3b31.3x28.6x0.8x
Thu, 12 Jun 2025CN¥93.9bCN¥120.4bCN¥3.3b31.9x28.8x0.8x
Sat, 10 May 2025CN¥95.3bCN¥120.2bCN¥3.2b30.5x29.8x0.8x
Mon, 07 Apr 2025CN¥91.6bCN¥121.0bCN¥3.9b21.7x23.5x0.8x
Wed, 05 Mar 2025CN¥83.8bCN¥121.0bCN¥3.9b19.3x21.5x0.7x
Fri, 31 Jan 2025CN¥80.6bCN¥121.0bCN¥3.9b18.6x20.7x0.7x
Sun, 29 Dec 2024CN¥88.3bCN¥121.0bCN¥3.9b20.4x22.6x0.7x
Tue, 26 Nov 2024CN¥86.8bCN¥121.0bCN¥3.9b19.4x22.2x0.7x
Thu, 24 Oct 2024CN¥85.3bCN¥119.6bCN¥4.3b19.8x19.7x0.7x
Sat, 21 Sep 2024CN¥69.2bCN¥119.6bCN¥4.3b15.7x16x0.6x
Mon, 19 Aug 2024CN¥71.8bCN¥118.4bCN¥4.8b16.1x15x0.6x
Wed, 17 Jul 2024CN¥76.7bCN¥118.4bCN¥4.8b18.2x16x0.6x
Fri, 14 Jun 2024CN¥105.3bCN¥118.4bCN¥4.8b25.2x22x0.9x
Sun, 12 May 2024CN¥127.0bCN¥118.4bCN¥4.8b26.7x26.5x1.1x
Tue, 09 Apr 2024CN¥115.3bCN¥114.8bCN¥5.2b20.9x22x1x
Thu, 07 Mar 2024CN¥113.3bCN¥115.9bCN¥5.8b19.7x19.5x1x
Sat, 03 Feb 2024CN¥111.5bCN¥116.0bCN¥5.7b19.6x19.4x1x
Mon, 01 Jan 2024CN¥128.1bCN¥116.0bCN¥5.7b22x22.3x1.1x
Wed, 29 Nov 2023CN¥130.4bCN¥116.0bCN¥5.7b22.9x22.7x1.1x
Fri, 27 Oct 2023CN¥110.4bCN¥113.6bCN¥5.7b21.2x19.5x1x
Sun, 24 Sep 2023CN¥120.7bCN¥113.6bCN¥5.7b23.4x21.3x1.1x
Tue, 22 Aug 2023CN¥130.2bCN¥109.7bCN¥5.4b27.7x23.9x1.2x
Thu, 20 Jul 2023CN¥125.7bCN¥109.7bCN¥5.4b26.6x23.1x1.1x
Sat, 17 Jun 2023CN¥135.1bCN¥109.7bCN¥5.4b28.6x24.8x1.2x
Price to Earnings Ratio

24.8x


Total Market Cap: CN¥135.1bTotal Earnings: CN¥5.4bTotal Revenue: CN¥109.7bTotal Market Cap vs Earnings and Revenue0%0%0%
Chinese Drug Retail Industry Price to Earnings3Y Average 23.1x202420252026
Current Industry PE
  • Investors are pessimistic on the Chinese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 18.3x which is lower than its 3-year average PE of 23.2x.
  • The industry is trading close to its 3-year average PS ratio of 0.85x.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have declined 8.2% per year over the last three years.
  • Meanwhile revenues for these companies have grown 3.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Chinese Drug Retail compare with similar industries?

CN Market-2.10%
Consumer Staples-5.21%
Food and Staples Retail-5.34%
Drug Retail-3.75%
Food Distributors-5.52%
Food Retail-6.14%
Big Box Super Stores-6.98%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
603939 Yifeng Pharmacy ChainCN¥20.690.8%
+CN¥206.1m
-19.3%PE14.5x

Latest News